What are the side effects of afatinib? How to deal with it scientifically?

Afatinib is an EGFR (epidermal growth factor receptor) inhibitor used to treat patients with non-small cell lung cancer (NSCLC). It effectively controls tumor growth by targeting and inhibiting EGFR mutations in cancer cells. However, as a targeted drug, afatinib may also cause certain side effects during treatment. Patients should be aware of common side effects and take appropriate management measures when using afatinib.

Common side effects of afatinib include rash, diarrhea, mouth sores, fatigue, loss of appetite, and liver damage. Rash is the most common side effect of afatinib, usually manifesting as red, dry, and itchy skin, and some patients may experience severe skin damage. To relieve skin discomfort, patients can use mild skin care products, avoid exposure to the sun, and can use oral antibiotics or topical medications as recommended by their doctor. Diarrhea is also a common side effect of afatinib. Patients can relieve symptoms by staying hydrated and taking anti-diarrhoea medications. In addition, patients should avoid spicy or greasy foods to reduce gastrointestinal irritation.

Mouth ulcers are another common side effect, and patients can reduce symptoms by maintaining oral hygiene, avoiding hot or irritating foods, and using gargles. During treatment, patients may also experience fatigue and loss of appetite. These symptoms are generally mild, but may affect quality of life after long-term use. Patients should ensure adequate rest and receive appropriate nutritional supplements.

In general, the side effects of afatinib are controllable, and patients need to handle it promptly according to the doctor's advice and do not stop taking the drug on their own. During the treatment process, close monitoring of the occurrence of side effects and scientific response according to individualized plans can effectively improve the treatment effect and quality of life.

Reference materials:https://www.giotrif.com/